Recombinant Mouse Lipocalin-2/NGAL/Lcn2 Protein, C-10*His tag
- 
									
产品编号
MOP2222
 - 
									
别名
脂质结合蛋白2, NRL, 24p3, Sip24, AW212229, lipocalin 2
 - 
									
规格
- 20ug
 - 50ug
 - 100ug
 - 200ug
 - 1mg
 
 
| Catalog Number | MOP2222 | 
| Alias | 脂质结合蛋白2, NRL, 24p3, Sip24, AW212229, lipocalin 2 | 
| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
| Product Description | MOP2222 Recombinant Mouse Lipocalin-2/NGAL/Lcn2 Protein, C-10*His tag contains the mouse Lcn2(Gln21-Asn200) was expressed in Mammalian cells. | 
| Molecular Name | Lcn2 | 
| Product Introduction | Lcn2 (MOP2222) 是一种参与免疫反应和炎症反应的脂质结合蛋白。 | 
| Molecular Weight | 26-27 kDa | 
| Expression System | HEK293F Cells | 
| Species | Mouse | 
| Concentration | 联系销售经理获得最新批次的浓度 | 
| Purity | ≥95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | P11672 | 
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
| Formulation | PBS | 
| Shipping Condition | This product is shipped on ice packs or dry ice. | 
| Background | Lipocalin-2(LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), 24p3, siderocalin, or neutrophil lipocalin (NL), is a 25-kDa secretory glycoprotein which is expressed in liver, lung, kidney, adipocytes, activated neutrophils, and macrophages. LCN2 appears to be upregulated in the case of information and infection conditions. Several reports suggest that LCN2 may represent a sensitive biomarker for various renal injuries and somehow may be involved in the pathophysiological process of some chronic renal diseases. | 
| Endotoxin | < 0.1 EU per ug | 
| Protein Family | Other protein | 
| Biological Activity | Measured by its ability to bind Iron(III) dihydroxybenzoic acid [Fe(DHBA)3]. The binding of Fe(DHBA)3 results in the quenching of Trp fluorescence in Lipocalin-2. >1.0 µM of Fe(DHBA) can be bound underthe described conditions. | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
							
							
							
							
						
								0